Syndax Pharmaceuticals, Inc.
SNDX
$11.05
-$0.28-2.47%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 582.91M | 406.40M | 432.27M | 443.16M | 577.58M |
| Total Receivables | 13.87M | 4.69M | 10.88M | 7.59M | 1.23M |
| Inventory | 366.00K | -- | -- | -- | -- |
| Prepaid Expenses | 5.30M | 3.51M | 2.85M | 3.07M | 2.00M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 612.00K | 218.00K | 62.00K | 83.00K | 63.00K |
| Total Current Assets | 603.06M | 414.81M | 446.06M | 453.90M | 580.88M |
|
|
|||||
| Total Current Assets | 603.06M | 414.81M | 446.06M | 453.90M | 580.88M |
| Net Property, Plant & Equipment | 2.02M | 756.00K | 1.00M | 1.25M | 1.50M |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 217.00K | 217.00K | 373.00K | 465.00K | 680.00K |
| Total Assets | 724.82M | 425.81M | 476.95M | 543.03M | 612.88M |
|
|
|||||
| Total Accounts Payable | 11.63M | 4.90M | 11.57M | 8.81M | 9.96M |
| Total Accrued Expenses | 59.68M | 47.91M | 26.59M | 32.32M | 38.97M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 12.60M | 852.00K | 993.00K | 1.05M | 1.05M |
| Total Finance Division Other Current Liabilities | 19.65M | 5.71M | 3.32M | 8.62M | 8.12M |
| Total Other Current Liabilities | 19.65M | 5.71M | 3.32M | 8.62M | 8.12M |
| Total Current Liabilities | 103.55M | 59.38M | 42.47M | 50.81M | 58.10M |
|
|
|||||
| Total Current Liabilities | 103.55M | 59.38M | 42.47M | 50.81M | 58.10M |
| Long-Term Debt | 331.57M | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 1.58M | 2.00K | 137.00K | 334.00K | 588.00K |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 436.69M | 59.38M | 42.61M | 51.14M | 58.68M |
|
|
|||||
| Common Stock & APIC | 1.51B | 1.49B | 1.48B | 1.47B | 1.46B |
| Retained Earnings | -1.22B | -1.13B | -1.04B | -974.80M | -902.40M |
| Treasury Stock & Other | 163.00K | 371.00K | -817.00K | -756.00K | 218.00K |
| Total Common Equity | 288.12M | 366.43M | 434.34M | 491.89M | 554.20M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 288.12M | 366.43M | 434.34M | 491.89M | 554.20M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 288.12M | 366.43M | 434.34M | 491.89M | 554.20M |
|
|
|||||